Identification of Plausible Candidates in Prostate Cancer Using Integrated Machine Learning Approaches.
Journal:
Current genomics
Published Date:
Dec 20, 2023
Abstract
BACKGROUND: Currently, prostate-specific antigen (PSA) is commonly used as a prostate cancer (PCa) biomarker. PSA is linked to some factors that frequently lead to erroneous positive results or even needless biopsies of elderly people.
Authors
Keywords
No keywords available for this article.